Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 16,142 Maze Therapeutics, Inc. shares (Form 4)

Traded Aug 13, 2026 · Filed Aug 14, 2026

On Aug 13, 2026, Bernstein Harold (President, R&D & CMO) sold 16,142 Maze Therapeutics, Inc. shares at US$27.61 for US$446K under a trading plan, leaving 0 shares. Filed Aug 14, 2026 (Form 4).

Sold: 16,142 shares
Price: US$27.61
Value: US$446K
Holding after: 0 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President, R&D & CMO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Aug 13, 2026	Common Stock	Option exercise	16,142	US$10.42	16,142	Direct
Aug 13, 2026	Common Stock	Sale	16,142	US$27.61	0	Direct

Source

View original at SEC

Related